A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

  • Leong, Rupert (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Parshionikar, Abhijit (Clinical Trial Unit Staff)

Project: Research

Project Details

AcronymM14-234
StatusActive
Effective start/end date17/12/1924/09/24